scorecardresearch
Saturday, April 27, 2024
TopicCancer treatment

Topic: Cancer treatment

India gets 1st homegrown CAR T-cell therapy centre at IIT-B. All about breakthrough cancer treatment

CAR T-cell therapy's a form of immunotherapy that uses body's immune cells called T-cells, a type of lymphocyte or white blood cell. It has been approved for various types of blood cancers.

Pill under Rs 100 to reduce cancer recurrence? Novel nutraceutical holds promise but it’s too early

Findings by Tata Memorial Centre suggest that resveratrol, when given with miniscule doses of copper, can reduce rate of metastasis & treatment-related toxicity in cancer patients.

All about India’s 1st ‘living drug’ that uses patient’s own genetically engineered cells to fight cancer

Patients already registering for CAR T-cell therapy, developed indigenously by ImmunoACT under the name NexCAR19. It will be used to treat leukemia & refractory or relapsed lymphoma.

Combination of 2 immunotherapy drugs can help liver cancer patients live longer, finds India study

Done by researchers from Hyderabad's Asian Institute of Gastroenterology & Jaipur's Mahatma Gandhi Medical College, study was published in 'Journal of Clinical & Experimental Hepatology'.

Tata Memorial Centre-led project makes waves with promise to cut cancer drug costs by up to 99%

23 hospitals from National Cancer Grid, a network of over 250 cancer centres, pilot ‘pooled procurement’ to improve negotiability for high-value oncology and supportive-care drugs.

Key takeaway from Modi-Biden meet: India, US reiterate commitment to collaborative cancer research

As part of upcoming India-US Cancer Dialogue, both countries are planning to focus on advancing knowledge in cancer genomics, developing new diagnostics, therapeutics etc.

Tata Memorial now 1st govt facility in India to offer breakthrough ‘proton therapy’ for cancer

Starting this week, Mumbai’s Tata Memorial Centre will offer ‘proton beam therapy’, which allows more targeted treatment of cancerous tumours and fewer side-effects.

Founder of Mumbai firm behind new pan-cancer blood test says it can detect disease at ‘imminent’ stage

According to the makers, this test can detect cancerous stem cells before tumours form with 'nearly 100 per cent' accuracy.

How are stars like Sun formed? James Webb Space Telescope images hold key to new investigations

ScientiFix, our weekly feature, offers you a summary of the top global science stories of the week, with links to their sources.

Why women with stage 4 breast cancer deserve more than unrelatable pink ribbons

Many women with metastatic breast cancer feel that little is done to showcase the less optimistic and more frightening aspects of the disease.

On Camera

Indira, Manmohan, Modi, all raised income inequality. Until Hindu fears took the driving seat

The issue of inequality has assumed the blazing limelight at a time when inequality in India is said to be higher than it was in the British Raj. It's a ripe situation for half-truths and incendiary statements.

Foreign policy resonating among more Indians in 2nd & 3rd tier towns of India, says EAM Jaishankar

Speaking at launch of economist Surjit Bhalla’s book, S Jaishankar also highlights Gen Z’s engagement with ‘reel culture’, which has 'promoted awareness, created interest in many subjects'.

Germany removes restrictions, India can now buy small arms from its firms

Germany’s erstwhile Christian Democratic Union govt, led by Angela Merkel, prevented sale of small arms to police forces in states they perceived had ‘bad human rights record’.

Frontrunner is letting the challenger define this poll campaign. Modi still hasn’t found a big theme

A theme has not yet emerged for BJP & people see lack of a contest, which makes it unexciting. For all these reasons, 2024 is turning out to be an unexpectedly theme-less election.